Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TrueBlue (TBI) Cash & Equivalents (2016 - 2025)

TrueBlue (TBI) has disclosed Cash & Equivalents for 17 consecutive years, with $24.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 8.76% to $24.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $24.5 million, a 8.76% increase, with the full-year FY2025 number at $24.5 million, up 8.76% from a year prior.
  • Cash & Equivalents was $24.5 million for Q4 2025 at TrueBlue, up from $19.9 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $105.2 million in Q2 2021 to a low of $14.5 million in Q3 2024.
  • A 5-year average of $43.6 million and a median of $40.2 million in 2022 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: soared 89.65% in 2021, then crashed 69.21% in 2024.
  • TrueBlue's Cash & Equivalents stood at $49.9 million in 2021, then skyrocketed by 44.41% to $72.1 million in 2022, then fell by 14.11% to $61.9 million in 2023, then crashed by 63.58% to $22.5 million in 2024, then grew by 8.76% to $24.5 million in 2025.
  • Per Business Quant, the three most recent readings for TBI's Cash & Equivalents are $24.5 million (Q4 2025), $19.9 million (Q3 2025), and $21.9 million (Q2 2025).